SUTTI, Salvatore
 Distribuzione geografica
Continente #
EU - Europa 1.015
NA - Nord America 711
AS - Asia 269
AF - Africa 4
Continente sconosciuto - Info sul continente non disponibili 1
SA - Sud America 1
Totale 2.001
Nazione #
US - Stati Uniti d'America 700
IE - Irlanda 314
DE - Germania 176
IT - Italia 172
SE - Svezia 144
UA - Ucraina 85
SG - Singapore 69
HK - Hong Kong 59
CN - Cina 57
FI - Finlandia 50
IN - India 47
FR - Francia 26
BE - Belgio 18
VN - Vietnam 18
TR - Turchia 12
CA - Canada 11
PL - Polonia 8
CZ - Repubblica Ceca 6
GB - Regno Unito 6
NL - Olanda 6
IR - Iran 4
NG - Nigeria 4
JP - Giappone 2
CH - Svizzera 1
CL - Cile 1
ES - Italia 1
EU - Europa 1
LT - Lituania 1
PK - Pakistan 1
RU - Federazione Russa 1
Totale 2.001
Città #
Dublin 305
Jacksonville 158
Dearborn 82
Chandler 59
Hong Kong 59
Singapore 51
Wilmington 42
Lawrence 33
Princeton 33
Piemonte 27
Turin 26
Novara 23
Ann Arbor 22
Bremen 21
Beijing 20
Grafing 20
Strasbourg 20
Brussels 18
Dong Ket 18
Milan 16
Ashburn 14
Helsinki 14
Monmouth Junction 13
San Mateo 13
Andover 12
Munich 11
Kocaeli 10
Odalengo Grande 8
Toronto 8
Mülheim 7
Woodbridge 7
Gdynia 6
Kunming 6
Leawood 6
Nanjing 6
Berlin 5
Brno 5
Santa Clara 5
Amsterdam 4
Bulandshahr 4
Cassano Magnago 4
Fairfield 4
Mumbai 4
Norwalk 4
Vercelli 4
Hefei 3
Nanchang 3
Rome 3
Augusta 2
Bologna 2
Cincinnati 2
Des Moines 2
Espoo 2
Frankfurt am Main 2
Fuzhou 2
Guangzhou 2
Houston 2
Karabağlar 2
London 2
New York 2
Padova 2
Seattle 2
Winnipeg 2
Zanjan 2
Aix-en-Provence 1
Altavilla Monferrato 1
Ardabil 1
Baotou 1
Barcelona 1
Boardman 1
Brugherio 1
Cambridge 1
Casale Monferrato 1
Castagnito 1
Changchun 1
Chengdu 1
Cicciano 1
Clearwater 1
Düsseldorf 1
Elk Grove Village 1
Fremont 1
Garden City 1
Hangzhou 1
Hebei 1
Jiaxing 1
Jinan 1
Lahore 1
Langfang 1
Nagpur 1
Ningbo 1
Ottawa 1
Prague 1
Redwood City 1
Riva Presso Chieri 1
Secaucus 1
Senden 1
Shenyang 1
Shimosakunobe 1
Slough 1
Stockholm 1
Totale 1.314
Nome #
Bias in macrophage activation pattern influences non-alcoholic steatohepatitis (NASH) in mice 92
Fat-laden macrophages modulate lobular inflammation in nonalcoholic steatohepatitis (NASH) 78
Adenosine A2a receptor stimulation prevents hepatocyte lipotoxicity and nonalcoholic steatohepatitis (NASH) in rats. 77
CX3CR1-expressing inflammatory dendritic cells contribute to the progression of steatohepatitis 76
Adaptive immunity: an emerging player in the progression of NAFLD 75
CX3CR1 Mediates the Development of Monocyte-Derived Dendritic Cells during Hepatic Inflammation 72
CX3CR1 modulates the anti-inflammatory activity of hepatic dendritic cells in response to acute liver injury 71
Inducible T-Cell Costimulator Mediates Lymphocyte/Macrophage Interactions During Liver Repair 71
The role of immune mechanisms in alcoholic and nonalcoholic steatohepatitis: A 2015 update 67
Adaptive immune responses triggered by oxidative stress contribute to hepatic inflammation in NASH 66
Is there a role for adaptive immunity in nonalcoholic steatohepatitis? 64
Hypoxia-inducible factor 2α drives nonalcoholic fatty liver progression by triggering hepatocyte release of histidine rich glycoprotein 63
Endogenous annexin A1 is a novel protective determinant in nonalcoholic steatohepatitis in mice. 57
Microvesicles released from fat-laden cells promote activation of hepatocellular NLRP3 inflammasome: A pro-inflammatory link between lipotoxicity and non-alcoholic steatohepatitis. 56
Annexin A1 treatment prevents the evolution to fibrosis of experimental nonalcoholic steatohepatitis 54
SerpinB3 promotes pro-fibrogenic responses in activated hepatic stellate cells 53
CYP2E1 autoantibodies in liver diseases 50
Notch signaling and progenitor/ductular reaction in steatohepatitis. 49
Serum autoantibodies against cytochrome P450 2E1 (CYP2E1) predict severity of necroinflammation of recurrent hepatitis C 47
Oncostatin M, A Profibrogenic Mediator Overexpressed in Non-Alcoholic Fatty Liver Disease, Stimulates Migration of Hepatic Myofibroblasts 46
Conformational anti-cytochrome P4502E1 auto-antibodies contributes to necro-inflammatory injury in chronic hepatitis C 45
Immune response against oxidative stress-derived antigens are associated with increased circulating tumor necrosis factor-α in heavy drinkers 44
NF-kB1 deficiency stimulates the progression of nonalcoholic steatohepatitis (NASH) in mice by promoting NKT-mediated responses 44
Breaking self-tolerance toward cytochrome P4502E1 (CYP2E1) in chronic hepatitis C: possible role for molecular mimicry 43
Liver inflammation and regeneration in drug-induced liver injury: Sex matters! 43
SerpinB3 Differently Up-Regulates Hypoxia Inducible Factors -1α and -2α in Hepatocellular Carcinoma: Mechanisms Revealing Novel Potential Therapeutic Targets 43
Interplay between oxidative stress and steatosis in the progression of Hepatitis C 41
SerpinB3 as a Pro-Inflammatory Mediator in the Progression of Experimental Non-Alcoholic Fatty Liver Disease 40
Lack of CC chemokine ligand 2 differentially affects inflammation and fibrosis according to the genetic background in a murine model of steatohepatitis. 40
Hepatocyte-Specific Deletion of HIF2α Prevents NASH-Related Liver Carcinogenesis by Decreasing Cancer Cell Proliferation 40
ICOSL Stimulation by ICOS-Fc Accelerates Cutaneous Wound Healing In Vivo 38
Oxidative stress parameters in paediatric non-alcoholic fatty liver disease 35
The paradox role of cytotoxic T-lymphocytes in NAFLD-associated hepatocellular carcinoma 35
Nrf2 Mutation/Activation Is Dispensable for the Development of Chemically Induced Mouse HCC 32
Cutting-Edge Delivery Systems and Adjuvants in Tolerogenic Vaccines: A Review 30
B2-Lymphocyte responses to oxidative stress-derived antigens contribute to the evolution of nonalcoholic fatty liver disease (NAFLD) 30
Oncostatin M is overexpressed in NASH-related hepatocellular carcinoma and promotes cancer cell invasiveness and angiogenesis 30
Differential Modulation of Human M1 and M2 Macrophage Activity by ICOS-Mediated ICOSL Triggering 20
Platelets, Protean Cells with All-Around Functions and Multifaceted Pharmacological Applications 19
Inflammatory processes involved in NASH-related hepatocellular carcinoma 18
Use of Poly Lactic-co-glycolic Acid Nano and Micro Particles in the Delivery of Drugs Modulating Different Phases of Inflammation 15
From MASLD to HCC: What's in the middle? 13
Role of the co-stimulatory molecule inducible T-cell co-stimulator ligand (ICOSL) in the progression of experimental metabolic dysfunction-associated steatohepatitis 11
Histidine-rich glycoprotein in metabolic dysfunction-associated steatohepatitis-related disease progression and liver carcinogenesis 11
Metabolic Reprogramming of HCC: A New Microenvironment for Immune Responses 10
Role of Balanced Involvement of the ICOS/ICOSL/Osteopontin Network in Cutaneous Wound Healing 8
Editorial: Inflammatory responses on the road from NASH to HCC: pathogenic mechanisms and possible therapeutic strategies 6
Totale 2.068
Categoria #
all - tutte 12.815
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 12.815


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020276 0 0 0 0 0 58 70 22 37 58 30 1
2020/2021217 27 0 28 4 22 8 27 4 34 13 28 22
2021/2022312 10 19 17 10 17 31 35 7 19 24 49 74
2022/2023690 75 31 39 14 49 66 31 21 316 2 33 13
2023/2024242 18 21 13 3 35 7 50 5 9 5 43 33
2024/2025118 8 8 45 12 31 14 0 0 0 0 0 0
Totale 2.068